While IL-6/STAT3/HIF1 signaling has been reported to play an important role in the treatment of ovarian cell cancer [35], the issue of whether the IL-6/STAT3/HIF1 pathway may play a role in laryngeal cancer remains uncertain. This evidence concerns the gene HIF1A and laryngeal carcinoma.